NO993825D0 - Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler - Google Patents

Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler

Info

Publication number
NO993825D0
NO993825D0 NO993825A NO993825A NO993825D0 NO 993825 D0 NO993825 D0 NO 993825D0 NO 993825 A NO993825 A NO 993825A NO 993825 A NO993825 A NO 993825A NO 993825 D0 NO993825 D0 NO 993825D0
Authority
NO
Norway
Prior art keywords
nucleic acid
formulation
acid particles
transfection agents
cationic transfection
Prior art date
Application number
NO993825A
Other languages
English (en)
Norwegian (no)
Other versions
NO993825L (no
Inventor
Joul Crouzet
Bruno Pitard
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO993825(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO993825L publication Critical patent/NO993825L/no
Publication of NO993825D0 publication Critical patent/NO993825D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO993825A 1997-02-10 1999-08-09 Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler NO993825D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
PCT/FR1998/000222 WO1998034648A1 (fr) 1997-02-10 1998-02-06 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (2)

Publication Number Publication Date
NO993825L NO993825L (no) 1999-08-09
NO993825D0 true NO993825D0 (no) 1999-08-09

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993825A NO993825D0 (no) 1997-02-10 1999-08-09 Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler

Country Status (20)

Country Link
EP (1) EP1007097B1 (cs)
JP (1) JP2001511171A (cs)
KR (1) KR20000070914A (cs)
AT (1) ATE206932T1 (cs)
AU (1) AU737720B2 (cs)
BR (1) BR9807563A (cs)
CA (1) CA2278665A1 (cs)
CZ (1) CZ282199A3 (cs)
DE (1) DE69802102T2 (cs)
DK (1) DK1007097T3 (cs)
ES (1) ES2166146T3 (cs)
FR (1) FR2759298B1 (cs)
GR (1) GR3036919T3 (cs)
HU (1) HUP0001720A3 (cs)
IL (1) IL130765A0 (cs)
NO (1) NO993825D0 (cs)
PT (1) PT1007097E (cs)
SK (1) SK282685B6 (cs)
WO (1) WO1998034648A1 (cs)
ZA (1) ZA981034B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
WO1999052858A2 (en) * 1998-04-08 1999-10-21 Celltech Therapeutics Limited Lipids
AU747597B2 (en) * 1998-07-20 2002-05-16 Inex Pharmaceuticals Corporation Liposomal encapsulated nucleic acid-complexes
AU2001241958A1 (en) * 2000-03-03 2001-09-17 Valentis, Inc. Improved poloxamer and poloxamine compositions for nucleic acid delivery
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
CA2426582A1 (en) * 2000-10-20 2002-08-08 Valentis, Inc. Gene delivery formulations and methods for treatment of ischemic conditions
EP1232758A1 (fr) * 2001-02-19 2002-08-21 Aventis Pasteur Polynucléotide formulé en vue d'un transfert intracellulaire amélioré
JP2007527431A (ja) 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
ZA200707352B (en) 2005-03-03 2009-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
JP4653242B1 (ja) 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
AU5527696A (en) * 1995-03-31 1996-10-16 Children's Hospital Medical Center Use of surfactants for introducing genetic material into lun g cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
ES2166146T3 (es) 2002-04-01
SK282685B6 (sk) 2002-11-06
HUP0001720A3 (en) 2001-10-29
AU737720B2 (en) 2001-08-30
NO993825L (no) 1999-08-09
BR9807563A (pt) 2000-02-01
EP1007097B1 (fr) 2001-10-17
PT1007097E (pt) 2002-04-29
DE69802102D1 (de) 2001-11-22
DE69802102T2 (de) 2002-03-14
WO1998034648A1 (fr) 1998-08-13
AU6298798A (en) 1998-08-26
ATE206932T1 (de) 2001-11-15
EP1007097A1 (fr) 2000-06-14
CZ282199A3 (cs) 1999-10-13
JP2001511171A (ja) 2001-08-07
IL130765A0 (en) 2001-01-28
FR2759298B1 (fr) 1999-04-09
HUP0001720A1 (hu) 2000-09-28
ZA981034B (en) 1998-08-11
CA2278665A1 (fr) 1998-08-13
GR3036919T3 (en) 2002-01-31
FR2759298A1 (fr) 1998-08-14
KR20000070914A (ko) 2000-11-25
DK1007097T3 (da) 2002-02-11
SK108299A3 (en) 2000-05-16

Similar Documents

Publication Publication Date Title
NO993825L (no) Formulering av stabiliserte, kationiske transfeksjonsmidler/nukleinsyrepartikler
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
EP0911039A3 (en) Drug-resin complexes stabilized by chelating agents
PT1123120E (pt) Formulacao medicinal em aerossol
TR199501321A2 (tr) Farmasötik bilesimler.
MX9804848A (es) Emulsiones estables que comprenden un ingrediente liquido hidrofobico.
BR9906916A (pt) Composição de revestimento em pó
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
WO1998038984A3 (en) Formulations for hydrophobic pharmaceutical agents
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
GR3007107T3 (cs)
YU8701A (sh) Nova oralna kompozicija
BR0207699A (pt) Produto para aplicação axilar
BR0015538A (pt) Emprego de polissiloxanos com grupos amino quaternários como coadjuvantes de formulação, e agentes contendo-os
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
WO2002017956A3 (en) Stabilized fgf formulations containing reducing agents
BR9811985A (pt) Dispositivo de dosagem
WO2002083891A3 (en) Nucleic acids for inhibiting hairless protein expression and methods of use thereof
NZ335804A (en) Bleaching formulation comprising formamidinesulfinic acid, an anti-coating agent and silica
PH11997055419B1 (en) Cleansing composition comprising color stabilizer(s) and surfactant(s)
WO2000021577A3 (en) Compositions
ATE310075T1 (de) Reinigungsmittelkomponente mit feinteiligen feststoffen
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
EP0891778A3 (en) Agents for the prevention and/or treatment of radiation-induced disorders
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application